Physician profile
Anjan Gupta
NPI 1780653154
$34,028.15
in general payments reported to CMS, 2019-2025
45 companies · $5,407 in 2025
The $5,407 reported for 2025 was more than what 84% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,196 · 2020: $4,978 · 2021: $4,035 · 2022: $1,325 · 2023: $3,092 · 2024: $5,995 · 2025: $5,407.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $7,800 · Food and Beverage: $5,195 · Travel and Lodging: $1,474 · Education: $25.66.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $7,800.00 |
| Food and Beverage | $5,194.57 |
| Travel and Lodging | $1,473.98 |
| Education | $25.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $24,031.66 | 2019-2025 | Indigo System |
| Medtronic, INC. | $1,308.85 | 2021-2025 | Onyx Frontier, Symplicity G3, Hawkone |
| Inari Medical, INC. | $977.00 | 2019-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Pfizer INC. | $913.12 | 2019-2025 | |
| Abbott Laboratories | $795.21 | 2019-2025 | Cardiomems, Jeti, Diamondback Peripheral |
| Novartis Pharmaceuticals Corporation | $699.54 | 2019-2025 | |
| Abiomed | $691.78 | 2019-2024 | Impella |
| Amgen INC. | $594.29 | 2019-2025 | Repatha, Repatha |
| Chiesi USA, INC. | $371.92 | 2019-2025 | Kengreal, Cleviprex |
| E.R. Squibb & Sons, L.L.C. | $351.38 | 2019-2025 | Eliquis, Camzyos |
| Medtronic Vascular, INC. | $332.32 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $327.01 | 2019-2025 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $307.98 | 2019-2025 | Farxiga, Wainua |
| Atricure, INC. | $297.86 | 2023-2025 | Synergy Ablation System |
| Merck Sharp & Dohme LLC | $190.61 | 2022-2024 | Verquvo |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anjan Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.